i OVERVIEW OF GOVERNANCE REGIME
Belgian corporate governance practices for listed companies have been partially codified in the new Belgian Code on Companies and Associations (BCCA) and the Royal Decree of 29 April 2019 implementing the Code on Companies and Associations. The BCCA contains mandatory provisions on, for example, the establishment of an audit and risk committee and a remuneration committee, requirements with respect to the determination and disclosure of executive remuneration, requirements for independent directors and the issuance of a corporate governance statement. Compliance with these mandatory provisions is ensured, for the most part, by the listed company's auditor and the Financial Services and Markets Authority (FSMA). For existing companies, associations and foundations, the BCCA is applicable since 1 January 2020. The articles of association of existing legal entities must be brought into line with the BCCA no later than 1 January 2024.
In addition, other financial and ad hoc disclosure requirements for listed companies are laid down in the Royal Decree of 14 November 2007 on the obligations of issuers whose financial instruments are admitted for trading on a regulated market. Listed companies must also disclose the transparency notices they receive from their shareholders pursuant to the Act of 2 May 2007 and the Royal Decree of 14 February 2008.
The other main source of guidance with respect to corporate governance for Belgian listed companies is the Corporate Governance Code 2020 (2020 Code),2 published on 5 May 2019. The 2020 Code is an initiative of the non-governmental Corporate Governance Committee, composed of representatives from bodies such as the FSMA (formerly the CBFA), the Federation of Belgian Enterprises, Euronext Brussels, the Belgian Institute of Chartered Accountants and the Central Economic Council. The FSMA monitors compliance by listed companies with the comply or explain principle applicable under the 2020 Code. The 2020 Code applies to companies incorporated in Belgium whose shares are admitted to trading on a regulated market (i.e., listed companies) as defined by the BCCA.
By Royal Decree of 12 May 2019, the 2020 Code was named the mandatorily applicable corporate governance code for certain listed Belgian companies, more specifically those whose shares are listed on a regulated market (in Belgium or another member state of the European Economic Area (EEA)) or whose shares are traded on a multilateral trading facility (MTF) (i.e., in Belgium, mainly the Vrije Markt/Marché Libre and Alternext),3 provided they have other securities listed on a regulated market (e.g., in Belgium, Euronext Brussels or the market for derivatives of Euronext Brussels). The BCCA obliges such companies to adhere to the provisions of the 2020 Code or to explain in their corporate governance statement, which forms part of the annual report, why they have not done so, assuming, of course, that the provisions in question are not of mandatory application. This means that listed companies are not required by law to comply with the 2020 Code, but they are required to explain why they have not done so. In addition, compliance is highly recommended since it gives credibility and authority to listed companies. Non-compliance can adversely affect public opinion about a company.
The Belgian corporate governance rules have thus evolved over the past few years from soft law (the Lippens Code and the 2009 Code) to hard law (BCCA), and the process is ongoing. The 2020 Code is a thorough review of the 2009 Code, incorporating numerous regulatory changes, both on European and Belgian level. European legislation is often the driving force behind Belgian legislative proposals.
This chapter, however, focuses only on the corporate governance rules applicable to listed companies.
Ii CORPORATE LEADERSHIP
i Board structure and practices
In Belgium, listed companies usually take the form of a limited company (NV/SA).4 Companies with other corporate forms can be listed if their shares are freely transferable.
The basic governance structure of an NV/SA is a one-tier model, whereby the board of directors holds all powers except those specifically reserved by law or the articles of association to the general meeting of shareholders. Limitations on the powers of the board of directors set out in the articles of association are not enforceable against third parties and have internal effect only. The board of directors should be composed of at least three directors (or two if there are only two shareholders in the company and the articles of association so provide).
The BCCA allows the board of directors to delegate the daily management of the company, and the external representation of the company in that respect, to another person, who may also be a director. Limitations on the powers of the daily manager, either set out in the articles of association or adopted by the board of directors, are not enforceable against third parties and have internal effect only. This person is generally known as the CEO, managing director or general manager. The board of directors still has authority to take decisions with respect to the delegated powers.
The BCCA allows companies to adopt a two-tier governance model if their articles of association provide for this possibility. This model already existed under the old BCC where the board of directors delegated (some of) its powers to a management committee, except those reserved to it by law and general corporate policy.
Under the new regime, however, the intention has been to create a more clearly delineated two-tier system using two newly introduced legal bodies: a management board and a supervisory board.
The supervisory board is responsible for general policy, overall strategy and supervision of the management board. It holds the same powers that would otherwise be held by the board of directors within the one-tier model, provided these powers are reserved to it pursuant to the BCCA. The supervisory board has at least three members, who reach decisions collegially. Its members are nominated and dismissed by the general assembly.
The management board exercises all management powers, provided these have not been reserved to the supervisory board in accordance with the BCCA. Similar to the supervisory board, the management board is a collegial body consisting of a minimum of three members. Their nomination and dismissal is controlled by the supervisory board.
The aim of the two-tier model is to entrust exclusive powers to the aforementioned bodies through the articles of association and the law. This duality is further highlighted by prohibiting overlapping membership. The CEO, for instance, cannot be a member of the supervisory board, let alone vote in it. Very few listed companies have adopted a two-tier governance model.
The BCCA has also introduced the possibility of a sole director model. This means that there is no longer a collegial body at board level. Instead, all powers are held by one single director, which can be a natural or a legal person. For listed companies, however, only an NV/SA with a collegiate board is eligible to be a sole director.5
The most common governance model in listed companies is the one-tier model, whereby the board of directors delegates daily management to the CEO, who is assisted by a number of executive managers (who may or may not be directors), for example, the chief operating officer, the chief financial officer or the chief legal officer. Together, they constitute the company's executive management. The powers of the executive managers, other than the CEO, to represent the company for the purposes of certain acts, derive from a special authorisation granted by the board of directors or the CEO.
In addition to representation by the CEO (for matters of daily management) and other executive managers (within the limits of their specific powers), the company can also be represented externally by a majority of its directors acting jointly, or by a person appointed to this end in the articles of association (often two directors acting jointly, the chair, the CEO, etc.). The company will be bound by any acts taken or obligations incurred by these individuals, even if the internal decision was not taken by the correct corporate organ (unless the counterparty acted in bad faith). Quantitative limitations (e.g., representation for transactions with a value of up to €100,000) on the external representation powers of the CEO or the persons appointed in the articles of association to represent the company are not enforceable against third parties and have internal effect only.
In the above model, the board of directors still has all powers to manage the company, but daily management is mostly handled by executive management. The board of directors, in actuality, mainly supervises the management of the company. The 2020 Code indicates that the board of directors is responsible for determining the company's values and strategy, its risk appetite and key policies. As a guideline, the board of directors should ensure that the necessary leadership and human and financial resources are available for the company to meet its objectives. In translating values and strategies into key policies, the board should pay attention to corporate social responsibility, gender diversity and diversity in general. In addition to general corporate policy, the board of directors should at least, in the context of its supervisory role:
- review the performance of executive management and the realisation of the company's strategy;
- approve the framework of internal control and risk management proposed by the executive management and review the implementation of this framework;
- take all necessary measures to ensure the integrity and timely disclosure of the company's financial statements and other material financial and non-financial information in accordance with applicable law;
- ensure that the company presents an integrated view of the company's performance in its annual report and that it contains sufficient information on issues of societal concern and the relevant environmental and social indicators;
- ensure that there is a process in place for monitoring the company's compliance with laws and other regulations, as well as for the application of internal guidelines relating thereto; and
- approve a code of conduct (or several activity-specific codes of conduct), setting out the expectations for the company's leadership and employees in terms of responsible and ethical behaviour. The board should monitor compliance with such code of conduct at least on an annual basis.
The 2020 Code states that the board of directors should take decisions in close consultation with the CEO regarding the structure of executive management and should determine the powers and duties of the executive managers. A mention to this effect should be included in the terms of reference of the board and of executive management. The board should ensure that executive management is able to perform its responsibilities and duties. In view of the company's values, risk appetite and key policies, executive management should have sufficient latitude to propose and implement corporate strategy. Executive management should, at least:
- be entrusted with the running of the company;
- put internal controls in place (i.e., systems to identify, assess, manage and monitor financial and other risks) without prejudice to the board's supervisory role that are based on a framework approved by the board of directors;
- present to the board complete, timely, reliable and accurate financial statements, in accordance with the applicable accounting standards and company policies;
- prepare the company's required disclosure of the financial statements and other material financial and non-financial information;
- present the board with a balanced and understandable assessment of the company's financial situation;
- provide the board of directors with all information necessary in a timely fashion for the board of directors to carry out its duties; and
- be responsible and accountable to the board for the discharge of its responsibilities.
The 2020 Code states that the board of directors should be composed of both non-executive directors, who do not participate in the company's daily activities, and executive directors, who belong to executive management and thus participate in the company's daily activities. The majority of the board should be made up of non-executive directors, at least three of whom are independent based on the criteria set out in Clause 3.5 of the 2020 Code. In Article 7:87, the BCCA limits its own definition of independent to not having a relationship with the company or an 'important' shareholder that would jeopardise independence. The board's composition should ensure that decisions are taken in the company's interest and should reflect gender diversity and diversity in general, as well as complementary skills, experience and knowledge. No individual or group of directors should dominate the board's decision-making process, and no individual should wield excessive decision-making powers. In January 2011, the Corporate Governance Committee, which issued the 2020 Code, issued an additional recommendation providing that within seven years, at least 30 per cent of board members should be women.
Article 7:86 of the BCCA stipulates that at least one-third (rounded to the nearest whole number) of the board of directors of companies whose securities are listed on a regulated market should be of a different gender to the other members. If the required number of directors of the less-represented gender is not met, the next appointed director should be of that gender. If not, the appointment shall be deemed null and void. The same holds true if an appointment would cause the number of directors of the other gender to drop below the required minimum.
For companies whose securities are admitted to trading on a regulated market for the first time, the requirement should be met as from the first day of the sixth financial year after the admission.6
If the required quota is not met, a board that meets the quota should be composed at the next general meeting. Otherwise, any financial or other benefit to which the directors are entitled by virtue of their office shall be suspended. These benefits will be reintroduced once the board meets the gender diversity requirement.
The 2020 Code assigns a clear role to the chairperson of the board of directors. The chair and the CEO should not be the same person, and there should be a clear division between duties related to the running of the board (chair) and the management of the company's business (CEO). This division of responsibilities should be clearly established, set out in writing and ratified by the board. The chair should cultivate a close relationship with the CEO, providing support and advice while fully respecting the CEO's executive responsibilities. As a guideline, the chair should stimulate effective interaction between the board and executive management. The chair is responsible for leading the board of directors and can be entrusted by the board with specific responsibilities. The chair should take the necessary measures to foster a climate of trust within the board, contribute to open discussion, allow constructive dissent and ensure support for the board's decisions. Once decisions are taken, all board members should be supportive of their execution. The chair7 determines the agenda for board meetings, after consultation with the CEO and the company secretary, and ensures that procedures relating to preparations for board meetings, deliberations, the adoption of resolutions and the implementation of decisions are properly followed. The chair, or as the case may be the chair and the CEO, is responsible for ensuring that the directors receive accurate, timely and clear information before the meetings and, where necessary, between meetings. All directors should receive the same information.
The BCCA obliges companies8 whose shares are listed on a regulated market to set up a remuneration committee composed of non-executive directors, a majority of whom should be independent.9 The members of the remuneration committee must possess the requisite level of expertise in the area of remuneration policy. The chair of the board of directors or another non-executive director should head the remuneration committee. The remuneration committee should meet at least twice a year and whenever it deems necessary to carry out its duties. The remuneration committee should report regularly to the board of directors on the exercise of its duties. The CEO should attend meetings of the remuneration committee when the committee is discussing the remuneration of executive management. The remuneration committee should submit proposals to the board of directors on the company's remuneration policy and on the individual remuneration of directors and executive managers and, where appropriate, on proposals to be submitted by the board of directors to the general meeting of shareholders (i.e., proposals on the remuneration of directors). The remuneration committee also prepares the remuneration report that forms part of the annual report and provides explanations on this report at the annual general meeting of shareholders.
The 2020 Code provides for practically the same requirements with respect to the remuneration committee. The 2020 Code further specifies, however, that the remuneration committee should have at least three members should advise the board on the adoption of a remuneration policy. In addition to a remuneration committee, the BCCA obliges companies whose securities are listed on a regulated market10 to set up an audit and risk committee composed of non-executive directors. At least one member should be independent,11 and at least one member of the committee must possess the requisite level of expertise in the area of accountancy and audits. The audit and risk committee should report regularly to the board of directors on the exercise of its duties and in any case when the board draws up the annual accounts, consolidated annual accounts and short-form financial statement (intended for publication). The audit and risk committee should:
- monitor the financial reporting process;
- monitor the effectiveness of the company's internal control and risk management systems;
- monitor the internal audit (if any) and its effectiveness;
- monitor the audit of the annual and consolidated accounts, including the follow-up of any questions and recommendations by the statutory auditor; and
- review and monitor the independence of the statutory auditor, in particular with respect to the provision of additional services to the company.
The statutory auditor should report to the audit and risk committee on key matters arising from the audit of the annual accounts, in particular on material deficiencies in the internal control of the financial reporting process. The statutory auditor shall confirm to the audit and risk committee annually, in writing, its independence from the company, inform the audit committee on an annual basis of any additional services provided to the company, and examine, together with the audit committee, the risks to its independence and the safeguards to be implemented to minimise these risks. The audit committee should make a proposal on the appointment or reappointment of the statutory auditor or external auditor, which should be placed on the agenda of the general meeting.
The audit and risk committee meets whenever it deems it necessary to perform its duties properly and at least four times a year. The audit and risk committee reports regularly to the board of directors on the performance of its duties, and in any case when the board of directors prepares the annual accounts, the consolidated annual accounts and, where appropriate, the abbreviated financial statements intended for publication.
The audit and risk committee should review the specific arrangements for raising concerns – in confidence – about possible improprieties in financial reporting or other matters. The audit committee should agree on arrangements whereby staff may inform the chair of the audit committee directly. If deemed necessary, arrangements should be made for the proportionate and independent investigation of such matters and for the appropriate follow-up actions.
The 2020 Code also calls for the establishment of an independent internal audit function with resources and skills adapted to the company's nature, size and complexity. If the company does not have an internal audit function, the need for such function should be reviewed at least annually.
The 2009 Code already introduced a third committee, namely the nomination committee, whose duties may also be exercised by the remuneration committee, in which case it shall be known as the remuneration and nomination committee. The nomination committee should have at least three members, a majority of whom should be independent non-executive directors. The chair of the board of directors or another non-executive director shall chair the nomination committee. The chair cannot preside over meetings of the nomination committee when the committee is discussing the appointment of the chair's successor. The nomination committee should make recommendations to the board with regard to the appointment of directors, the CEO and other executive managers, and should consider proposals made by relevant parties, including management and shareholders. It should meet at least twice a year and review (at least every two to three years) its terms of reference and its own effectiveness and recommend any necessary changes to the board.
The 2008 financial crisis led to an animated debate on the (at times excessive) remuneration of directors and executive managers of Belgian companies. In an attempt to rein in the remuneration of directors and executive managers, several new provisions were adopted in 2010 and codified in the BCC and subsequently the BCCA.
As a general rule, the general meeting of shareholders has exclusive power to determine the remuneration of directors. The board of directors, in turn, determines the remuneration of executive management, unless the company's articles of association provide otherwise. In listed companies, the articles of association sometimes provide that the shareholders' general meeting determines the overall remuneration for the board of directors as a whole, while the board itself decides how to distribute this total amount among its members.
The BCCA stipulates that the remuneration of individual directors and executive managers shall be determined further to a proposal by the remuneration committee. The remuneration committee should also submit proposals on the company's remuneration policy, which must be explained in the remuneration report that forms part of the board's annual report. The general meeting of shareholders need not approve the remuneration policy per se in accordance with the BCCA, but does have the power to vote on the remuneration report in which the remuneration policy is described.12 There are no consequences, however, if the general meeting rejects the remuneration report. The remuneration report should also be provided to the works council or, in the absence thereof, the employee representatives on the committee for prevention and protection at work or, if there is no such committee, the trade union representatives.
If an executive manager receives variable remuneration (i.e., remuneration linked to performance), the criteria used to determine the remuneration should be set out in the contractual or other provisions governing the company's relationship with the manager, and payment can only take place if these criteria have been met within the specified time period. If this is not the case, the executive's variable remuneration cannot be taken into account to determine his or her severance package.
If the variable remuneration of an executive manager of a listed company makes up more than one-quarter of his or her annual remuneration, at least 25 per cent of the variable remuneration should be based on previously established and objectively verifiable performance criteria measured over a period of at least two years, and at least another 25 per cent should be based on previously established and objectively verifiable performance criteria measured over a period of at least three years, unless the articles of association provide otherwise or the general meeting of shareholders expressly consents to deviate from this rule.
Unless the articles of association provide otherwise or the general meeting of shareholders expressly agrees, shares shall only be finally acquired, and share options or any other rights to acquire shares shall only be exercisable, by a director or executive manager of a listed company after a holding period of at least three years is satisfied.
The general meeting of shareholders should also approve in advance13 any severance package agreed by the company with an executive manager if the severance pay amounts to more than 12 months' remuneration, as well as any variable remuneration granted to an independent or non-executive director.14 If the severance package represents more than 18 months' remuneration, a reasoned opinion from the remuneration committee is also required. Any such contractual provision that has not been approved by the general meeting shall be deemed null and void. The proposal should also be notified to the works council or, if there is none, the employee representatives on the committee for prevention and protection at work or, in the absence thereof, the union representatives.
The aforementioned provisions of the BCCA are supplemented by the 2020 Code principles and best practices with regard to the level and structure of executive remuneration. The board should adopt a remuneration policy based on the advice of the remuneration committee in order to achieve the following objectives:
- to attract, reward and retain the necessary talent;
- to promote the achievement of strategic objectives in accordance with the company's risk appetite and behavioural norms; and
- to promote sustainable value creation.
The board needs to ensure that the remuneration policy is consistent with the overall remuneration framework of the company. The board can decide to submit the policy to the general shareholders' meeting for approval ('comply or explain' principle of the 2020 Code). When a significant proportion of the votes have been cast against the remuneration policy, the company should take the necessary steps to address the concerns of those who vote against it, and consider adapting the policy.
Further to a special recommendation of the remuneration committee, the severance package can amount to 18 months' fixed and variable remuneration. In any case, the severance package should not take into account variable remuneration or exceed 12 months' fixed remuneration if the departing CEO or executive manager did not meet the agreed performance criteria. The 2009 Code also adds that the prior approval of the general meeting of shareholders is required for schemes that provide for the remuneration of executive managers with shares, options or any other right to acquire shares.
The 2020 Code further provides that the remuneration of non-executive directors should take into account not only their role as ordinary board members but also any specific positions they may hold, such as chair of the board, or chair or member of a board committee, as well as their resulting responsibilities and commitments in terms of time, and that non-executive directors should not be entitled to performance-based remuneration such as bonuses, long-term stock-based incentive schemes, or fringe or pension benefits. The 2020 Code also stipulates that non-executives board members should receive part of their remuneration in the form of shares in the company. These should be held until at least one year after the non-executive board member leaves the board and at least three years after the moment of award. However, no stock options should be granted to non-executive board members.
With regards to executive board members' remuneration, the remuneration policy should describe the different components of and determine an appropriate balance between fixed and variable remuneration, and cash and deferred remuneration. The variable remuneration for the executive director should be structured to link reward to overall corporate and individual performance, and to align the interests of the executives with the sustainable value-creation objectives of the company. When the company awards short-term variable remuneration to the executive management, this remuneration should be subject to a cap.
Since the financial crisis, remuneration schemes for executives (such as stock options and incentive compensation) were deemed to be overly focused on short-term results. These additional requirements concerning the remuneration policy are a result of the 2020 Code's broader emphasis on sustainable value creation and long-term growth.
The 2020 Code indicates that both executive and non-executive directors, regardless of whether the latter are independent or not, should exercise independence of judgement in their decisions. Directors should make sure they receive detailed and accurate information and should study this information carefully so as to acquire and maintain a clear understanding of the key issues relevant to the company's business. They should seek clarification whenever they deem it necessary to do so.
Non-executive directors should be made aware of the extent of their duties at the time of their appointment, in particular the time commitment involved. They should not consider taking on more than five directorships in listed companies. Changes to commitments and the assumption of new commitments outside the company should be reported to the chairperson of the board as they arise.
Pursuant to the BCCA, a director can be either a natural person or a legal entity. In the latter case, a permanent representative should be appointed from among the entity's shareholders, directors, members of executive management or personnel who is solely responsible for performing this office in the name and on behalf of the legal entity. The representative shall be liable for the performance of this office as if he or she had been appointed in his or her own name, notwithstanding the joint liability of the legal entity that is represented. The directors of autonomous governmental companies, public institutions and any legal entities over which the state exerts direct or indirect influence15 must be natural persons if they are remunerated for the directorship.16 Any payment to a legal entity, acting as director, in this case will be deemed null and void. A listed company that falls into any of the aforementioned categories (e.g., Proximus Group NV) must ensure that its remunerated directors are natural persons.
Directors cannot use the information obtained in their capacity as directors for purposes other than the exercise of their functions. They have an obligation to treat confidential information received in their capacity as directors with care.
Each board member should place the company's interests above their own. The board members have a duty to look after the interests of all shareholders on an equivalent basis. Each board member should act according to the principles of reasonableness and fairness. Board members should inform the board of any conflict of interests that could in their opinion affect their capacity of judgement. In particular, at the beginning of each board meeting, board members should declare whether they have any conflicts of interests regarding the items on the agenda. When a board member takes a decision, he or she should disregard their personal interests. They should not use business opportunities intended for the company for their own benefit.
In the possible case of a conflict of interests, the board should, under the lead of its chair, decide which procedure it will follow to protect the interests of the company and all its shareholders. In the next annual report, the board should explain why they chose this procedure. However, where there is a substantial conflict of interests, the board should carefully consider communicating as soon as possible on the procedure followed, the most important considerations and the conclusions. This disclosure should be effected through two different documents: the Corporate Governance Charter, posted on the company's website, and the Corporate Governance Statement, a specific section of the annual report. The BCCA indicates a specific procedure to be followed when directors have a pecuniary conflict of interest with the company. In listed companies, a director with a conflict of interest of a financial nature cannot participate in the deliberations or vote on the decision in question.
The board should also take all necessary and useful measures to ensure effective and efficient execution of the Belgian rules on market abuse. It should draw up a set of rules (the dealing code) regulating transactions (and the disclosure thereof) in shares of the company or in derivatives or other financial instruments linked to shares carried out for their own account by directors or other persons with managerial authority.
Directors can be held liable for shortcomings in the performance of their official duties in accordance with the applicable statutory provisions. For a violation of the law or the company's articles of association, directors can be held jointly and severally liable (unless they were not personally involved in the violation and brought it to the attention of the company's shareholders at the first general meeting after becoming aware of it). In addition, directors can be held liable in a number of specific circumstances (e.g., in the event of bankruptcy, a conflict of interest or tax liability).
Although the term of office of a director in an NV/SA cannot exceed six years by law, the 2020 Code advises setting the maximum term of directors at four years. The 2020 Code indicates that the board of directors should establish nomination procedures and selection criteria for its members, including specific rules for executive and non-executive directors where appropriate. The nomination committee should lead the nomination process and recommend suitable candidates to the board. The board should then make appointment proposals or re-appointment proposals to the general shareholders' meeting. For any new appointment to the board, the skills, knowledge and experience of existing board members and those needed on the board should be evaluated and, in the light of that assessment, a description of the role and skills, experience and knowledge should be prepared. For a director to qualify as independent, a number of criteria should be met.17
Companies whose securities are listed on a regulated market18 must publish annually and biannually19 a financial report. These listed companies are also obliged to publish ad hoc information if the information in question can be considered inside information. The annual financial report must contain:
- the annual accounts and consolidated annual accounts;
- the board's annual report (including the BCCA's requirements, such as the corporate governance statement and remuneration report);
- a number of specific items that could have consequences in the event of a takeover20 (e.g., shareholder agreements or limitations on the transferability of shares and securities);
- the statutory auditor's report; and
- a declaration by the issuer on the faithful nature of the accounts and report.
If the issuer decides to publish a communication between the end of the financial year and the publication of the annual financial report, this communication should meet certain criteria. The biannual financial report should contain interim financial statements and an interim report, information on external control and a declaration by the issuer regarding the faithful nature of the statements and report.
Listed companies are subject to other disclosure requirements with respect to any changes in the conditions, rights and guarantees linked to their securities, special reports of the board of directors and draft amendments to the articles of association. Listed companies should also disclose the transparency notices they receive from their shareholders in accordance with the Act of 2 May 2007 and the Royal Decree of 14 February 2008.
In addition to the disclosures set out above, the 2020 Code indicates that the company should draw up a corporate governance charter describing the main aspects of its corporate governance policy, such as its governance structure, the terms of reference of the board and its committees as well as other important topics. It should contain the minimum information set out in the 2020 Code. The charter should be updated as often as necessary to reflect the company's corporate governance at all times. It should be made available on the company's website and should specify the date of its most recent update.
The corporate governance charter should include at least:
- a description of the company's governance structure and the terms of reference of its board of directors;
- the policy established by the board for transactions and other contractual relationships between the company, including related companies, and board members and executive managers, to the extent not covered by the statutory provisions on conflicts of interest;
- the measures taken by the company to comply with the Belgian rules on market abuse;
- the terms of reference of each board committee;
- the terms of reference of executive management;
- the identity of major shareholders, with a description of their voting rights and special control rights, and, if they act in concert, a description of the key elements of existing shareholders' agreements;
- any other direct and indirect relationships between the company and its major shareholders; and
- a statement that the company has adopted the 2020 Code as its reference code.
The board of directors should also include a corporate governance statement in its annual report, describing all relevant corporate governance events that have taken place in the past year. This statement should be included in a specific section of the annual report and should contain the minimum information set out in the 2020 Code. If the company has not complied fully with one or more provisions of the Code, it should explain its reasons for not doing so in its corporate governance statement (the comply or explain principle). The BCCA has made a corporate governance statement mandatory.
Pursuant to the BCCA, the following items should be disclosed in the corporate governance statement in the company's annual report:21
- a statement that the company has adopted the 2020 Code as its reference code and the place where the 2020 Code can be consulted, as well as relevant information on the corporate governance practices applicable in addition to the 2020 Code and the place where these can be consulted;
- if the company does not fully comply with the 2020 Code, an indication of the provisions of the 2020 Code that were not complied with during the year and an explanation for the non-compliance;
- a description of the main features of the company's internal control and risk management systems in relation to financial reporting;
- the shareholder structure on the closing date of the financial year as it appears from the notifications the company received;
- the holders of securities to whom special control rights have been granted and a description of these rights;
- any limitations on voting rights provided for by law or the company's articles;
- the rules for the appointment of directors and amendments to the company's articles of association;
- the powers of the board of directors, specifically the possibility to issue or purchase own shares;
- a description of the composition and running of the board of directors and its committees. The 2009 Code adds that this description should include at least:
- a list of all board members, indicating which are independent;
- information on any directors who have ceased to meet the requirements for independence;
- an activity report on board and board committee meetings, indicating the number of board committees;
- information on meetings and the individual attendance records of directors;
- a list of all members of board committees;
- if applicable, an explanation as to why the appointment of the former CEO as chair is in the best interests of the company; and
- a list of all members of executive management; and
- an overview of the efforts taken to ensure that at least one-third of the members of the board of directors are of a different gender than the other members.
The BCCA indicates that the corporate governance statement should also include a remuneration report, prepared by the board of directors further to a proposal of the remuneration committee.
The following information should be disclosed in the remuneration report pursuant to the BCCA:
- a description of the company's internal procedure to develop a remuneration policy for directors and executive managers and set the level of individual remuneration for directors and executive managers;
- the remuneration policy for directors and executive managers containing at least the following items of information:
- the principles on which remuneration is based, including the relationship between remuneration and performance;
- the importance of the various components of remuneration;
- the characteristics of performance-based bonuses in the form of shares, share options or other rights to acquire shares; and
- information on the remuneration policy for the next two years. Furthermore, any significant changes to the remuneration policy since the end of the financial year should be expressly mentioned;
- the individual remuneration and other benefits granted directly or indirectly by the company, or another company that falls within the same scope of consolidation, to non-executive directors;
- the remuneration granted to executive managers who are also directors, but in that case only the remuneration received in their capacity as directors. It is unclear whether this information should be disclosed on an individual or collective basis;
- if the executive managers receive variable remuneration linked to the performance of the company, a company that falls within the same scope of consolidation as the company or a business unit of the company or their own performance, the criteria used to evaluate the achievement of the specified goals, the evaluation period and a description of the methods applied to verify whether the performance criteria are met. This information should be disclosed in such a way as to prevent the disclosure of confidential information about the company's strategy;
- the remuneration and other benefits granted directly or indirectly to the CEO22 by the company or a company that falls within the same scope of consolidation, indicating:
- base remuneration;
- variable remuneration: for all incentives, the form in which the variable remuneration is paid;
- pension benefits: the amounts paid or the value of services provided during the financial year, per pension scheme, with an explanation of the applicable pension schemes; and
- other components of remuneration, such as the cost or monetary value of insurance coverage and fringe benefits, with an explanation of the details of the main components. Moreover, any significant changes to the remuneration policy since the end of the financial year should be expressly mentioned;
- on a collective basis, the remuneration and other benefits granted directly or indirectly to other members of executive management (excluding the CEO) by the company or a company that falls within the same scope of consolidation, with a breakdown between:
- base remuneration;
- variable remuneration: for all incentives, the form in which the variable remuneration is paid;
- pension benefits: the amounts paid or the value of the services granted during the financial year, per pension scheme, with an explanation of the applicable pension schemes; and
- other components of remuneration, such as the cost or monetary value of insurance coverage and fringe benefits, with an explanation of the details of the main components. In addition, any significant changes to the remuneration policy since the end of the financial year should be expressly mentioned;
- for each executive manager (including the CEO):
- the number and key features of shares, share options or any other rights to acquire shares granted, exercised or expired during the financial year;
- the provisions on severance pay; and
- whether the company has the right to recover any variable remuneration granted on the basis of incorrect financial data;
- if an executive manager (including the CEO) leaves the company, the decision of the board of directors, further to a proposal of the remuneration committee, on whether the person is eligible to receive a severance package and the method used to calculate the severance pay.
IV CORPORATE RESPONSIBILITY
The Belgian corporate governance rules do not specifically cover corporate responsibility, with the exception of Article 7:86 BCCA, which provides that at least one-third (rounded to the nearest whole number) of the board members of companies whose securities are listed on a regulated market should be of a different gender. The 2020 Code moreover mentions that the composition of the board should be determined so as to gather sufficient expertise in the company's areas of activity as well as sufficient diversity of skills, background, age and gender.
The 2020 Code is characterised by a stronger emphasis on sustainable value creation. This involves an explicit focus on the long term, on responsible behaviour at all levels of the company and on the permanent consideration of the legitimate interests of stakeholders. More explicit expectations are also formulated in terms of diversity, talent development and succession planning, and in relation to the company's annual reporting on non-financial matters.
Unlike financial institutions, which have specific rules on compliance policies and risk management, there are currently only a limited number of rules on compliance and risk management for listed companies. The main provision in the 2020 Code is that an independent internal audit function should be established, with resources and skills adapted to the company's nature, size and complexity, and that if the company does not have such a position, the need for one should be reviewed at least annually. The effectiveness of the internal control and risk management systems set up by executive management should be monitored by the audit committee at least once a year, with a view to ensuring that the main risks (including those relating to fraud and compliance with existing legislation and regulations) are properly identified, managed and disclosed in accordance with the procedures approved by the board.
The 2020 Code further indicates that the audit and risk committee should review the specific arrangements for raising concerns – in confidence – about possible improprieties in financial reporting or other matters. The audit and risk committee should agree on arrangements whereby staff may inform the chair of the audit committee directly. If deemed necessary, arrangements should be made for the proportionate and independent investigation of such matters, appropriate follow-up actions and schemes whereby staff can inform the chairperson of the audit committee directly. It should be noted that the rules on personal data protection should of course be respected when establishing a whistle-blowing scheme.
On 18 December 2014, the Institute of Internal Auditors Belgium and the Institute of Company Auditors, together with the Belgian Association of Listed Companies, issued further practical guidelines for an effective relationship between the audit committee, the internal auditor and the external auditor. These guidelines are supported by the Corporate Governance Committee.
i Shareholder rights and powers
The basic rule is that each share of the same value carries one vote. If the shares do not have the same value or if there is no value mentioned, the shares carry voting rights in proportion to the capital they represent, with the share with the lowest value carrying one vote. Fractions of votes are not taken into account.23
The BCCA introduces a new multiple voting rights regime. For listed companies, this regime is restricted and only offers the possibility for the issuance loyalty shares with double voting rights (i.e., maximum 2 votes per share). The BCCA utilises an 'opt-in' system for companies wishing to avail themselves of the loyalty share regime. One vote per share remains the default system.
It requires a change to the company's articles of association, which needs to be approved by a two-thirds majority in the general assembly. Notably, this threshold is lower than the majority required for any other type of change to the articles of association.
The regime applies only to shares that have been registered in the name of the same shareholder for a continuous period of at least two years. The two-year period starts on the day on which the registered shares are registered, even if that registration took place before the statutory provision introducing the double voting right was adopted and before the company was listed. Every share that is converted into a dematerialised share or whose ownership is transferred loses double voting rights.
However, the transfer of shares as a result of succession, liquidation of matrimonial property regime or transfer, for pecuniary interest or free of charge, to the benefit of a beneficiary does not result in the loss of the double voting right and does not interrupt the required two-year period. The same applies in the event of transfer of shares between companies that have been controlled by the same shareholder ('intragroup transfers'), or in the case of joint control, by the same shareholders, natural or legal persons, or between one of these companies and these controlling shareholders. Controlling shareholders often have the right to appoint a majority of the company's directors, so that they de facto influence the management of the company.
Any powers not granted by law or the company's articles of association to the general meeting of shareholders are reserved to the board of directors. A number of decisions are reserved by law to the general meeting and cannot be delegated24 to the board of directors, such as approval of the annual accounts and discharge of the directors and statutory auditor, the final appointment of directors and the statutory auditor, the initiation of claims by the company against the directors, dissolution of the company, or a merger or a division. In 2010, a number of decisions relating to the remuneration of executive managers and directors were also made subject to the approval of the general meeting.
In general, a validly adopted decision of the general meeting of shareholders is, by law, binding on dissenting shareholders or shareholders who did not attend the meeting. Any party that can prove standing, including a shareholder, may, however, seek to invalidate a decision of the general meeting on account of:
- a formal irregularity, provided this irregularity could have influenced the decision;
- a violation of the procedural rules of the general meeting or the passage of a resolution on an item that was not on the agenda, provided there is fraudulent intent;
- an ultra vires act or abuse of power;
- the exercise of suspended voting rights, if this influenced the adoption of the decision; or
- any other reason set out in the BCCA.
In addition, dispute resolution procedures are available to shareholders pursuant to which they can be obliged to sell their shares or purchase the shares of other shareholders in the event of a serious conflict among them (Articles 2:60 to 2:69 BCCA, or the involuntary dissolution of the company can be requested as a last resort (Article 7:230 BCCA).
One or more shareholders who, individually or collectively, hold 10 per cent of the share capital can also request the board of directors and the statutory auditor to call a general meeting. It is generally accepted that these shareholders also have the possibility to determine the agenda for the meeting. In accordance with Article 7:130 of the BCCA, shareholders holding at least 3 per cent of the share capital of a listed company have the right to submit proposals regarding items on the agenda and propose resolutions (this does not apply to meetings held on second call: i.e., meetings called because the required quorum was not met at the first meeting).
Shareholders also have the right to ask the directors (and the statutory auditor) questions during general meetings or in writing before the meeting (to be answered at the meeting). The directors or the statutory auditor, as the case may be, have a duty to answer these questions. There is, however, an exception to this rule: directors and the statutory auditor can refuse to answer a question if doing so would cause harm to the business of the company or violate their or the company's duty of confidentiality. Questions should relate to items on the agenda or to a report prepared by the board of directors or the statutory auditor. Questions on the same topic may be consolidated and answered together.
One or more shareholders owning at least 95 per cent of the securities to which voting rights are attached can initiate a squeeze-out to obtain 100 per cent of all voting securities or securities that allow their holders to acquire voting securities.
ii Shareholders' duties and responsibilities
The 2020 Code stipulates that, in companies with one or more controlling shareholders, the board should endeavour to have the controlling shareholders make considered use of their position and respect the rights and interests of minority shareholders. The board should encourage the controlling shareholders to respect the 2020 Code. In addition, it is recommended to enter into a relationship agreement with the majority shareholders.
The 2020 Code also specifically mentions some best practices with regards to institutional investors. Namely that the company should discuss with institutional investors the implementation of their policy on the exercise of institutional investors' voting rights in the relevant financial year and ask institutional investors and their voting agencies for explanations on their voting behaviour.
Furthermore, the board should encourage shareholders, and in particular, institutional investors, to communicate their evaluation of the company's corporate governance prior to the general shareholders' meetings and at least through participation in the general shareholders' meeting. The general rule of law that minority shareholders can seek to invalidate a resolution of the general meeting on the grounds of abuse of majority still applies, of course. Such a request must be made within six months of the time the resolution became enforceable against the shareholder or was notified to the shareholder. Pursuant to this principle, a resolution can be invalidated if the voting rights were not exercised in the company's interest or the voter abused his or her rights, meaning the voting rights were exercised in an obviously unreasonable manner.
iii Shareholder activism
The general meeting of shareholders normally determines the remuneration of directors, but not of executive managers (except for the approval of severance pay in certain cases), so it does not have a complete say on pay. The general meeting of shareholders has the power to vote separately on the remuneration report in which the remuneration policy is described, but there are no legal consequences if it rejects the report.
If one or more shareholders do not agree with the board's management of the company, there is judicial relief available to them.
The BCCA does not contain express rules on the invalidation of resolutions by the governing body (i.e., the board of directors); however, based on general rules of law, the courts tend to accept that resolutions of the board of directors can be declared null and void at the request of any interested party (including a shareholder).
In general, the grounds for invalidating resolutions of the board of directors are the following:
- violation of the convocation formalities or procedural requirements for the meeting;
- violation of rules of law or the articles of association (e.g., an ultra vires act);
- resolutions that are obviously in violation of the company's interests; and
- resolutions adopted fraudulently.
Directors can be held liable, in accordance with the BCCA, for shortcomings in their management of the company, breach of rules of law or the articles of association and, in certain cases, violation of their general duty of care (the relevant standard is how a reasonably prudent director would have acted under the same circumstances). The general meeting of shareholders has the power to initiate proceedings on behalf of the company against one or more directors on the above-mentioned grounds. Such a decision should be approved by a majority of votes cast. No action can be taken if the general meeting has already discharged the directors. There is also a possibility for minority shareholders to initiate the same proceedings on behalf of the company if they represent at least 1 per cent of the voting securities or hold at least €1.25 million of the company's capital on the day the general meeting voted to discharge the directors. Minority shareholders that validly approved the discharge cannot bring such proceedings.
At the request of one or more shareholders holding at least 1 per cent of the total voting rights or securities that represent at least €1.25 million of the company's capital, the court may also appoint, if there are indications that the interests of the company are seriously jeopardised or could be jeopardised, one or more experts to verify the company's books and accounts and the actions of its corporate bodies.
In certain cases, one or more shareholders can also request the appointment of a temporary administrator to manage the company in lieu of the board of directors.
The BCCA provides for the possibility to solicit proxies for certain shareholder meetings. This solicitation should, however, comply with the requirements of the BCCA.25 A public solicitation of proxies (i.e., when advertisements or intermediaries are used or if more than 50 shareholders are targeted) should be approved by the FSMA and a number of requirements should be met.26 Proxy solicitation is mostly done by associations that defend (minority) shareholders' rights.
Several associations that defend (minority) shareholders have campaigned to involve as many shareholders as possible in certain proceedings (e.g., the Fortis case in 2008, the case against the National Bank of Belgium in 2010, the Lernout & Hauspie case, the Madoff case and the Lehman Brothers case).
Pursuant to the Act of 28 March 2014,27 class actions are now possible in Belgium. However, certain limitations apply. A class action may only be brought against a company, by a consumer, and for breach of a contractual obligations or a specific law. Thus, shareholders who would like to introduce a claim against (current or former) directors cannot bring a class action under Belgian law. Therefore, only investors that take part in the proceedings against a company have the right to claim damages.
iv Takeover defences
In general, the following measures can be taken by the target company to frustrate a takeover bid:
- Capital increase with the issuance of new shares: in principle, only the general meeting of shareholders is entitled to increase the company's share capital, unless the board of directors has been authorised to do so (pursuant to the BCCA). However, such an authorisation is not valid in the context of a takeover bid, during which the board, in principle, cannot increase the share capital by means of a contribution in kind or in cash with the cancellation or restriction of the shareholders' pre-emptive right. The general meeting may, however, authorise the board of directors to increase the share capital during the offer period by means of a contribution in kind or in cash with cancellation or restriction of the shareholders' pre-emptive right, provided:
- the board has been specifically authorised to do so within the past three years;
- the newly issued shares are fully paid up;
- the number of new shares does not exceed 10 per cent of the number of existing shares; and
- the subscription price is at least equal to the offer price.
- Acquisition of own shares by the company: in principle, the general meeting of shareholders must authorise the acquisition of own shares by the company unless the board of directors has been authorised to do so (pursuant to the BCCA). However, such an authorisation is not valid during a takeover bid, as from the time the company is notified of the bid by the FSMA. As an exception to this rule, the board may acquire own shares to avoid serious, imminent harm to the company, provided the articles of association so allow (for a maximum period of three years). In this case, other conditions governing the acquisition of own shares also apply.
- Poison pill: in general, certain advance measures are available to protect companies against potential takeover bids. However, pursuant to Article 7:151 of the BCCA, only the general meeting of shareholders (thus not the board) can grant rights to third parties liable to affect the company's assets or give rise to a debt or obligation on behalf of the company, when the exercise of the rights depends on the launch of a takeover bid or a change in control. To be valid, the resolution to this effect should be filed with the clerk's office (of the competent court) prior to the FSMA's notification of the bid to the company. During the offer period, only the target company's (general meeting of) shareholders can take decisions or execute transactions that could have a significant impact on the composition of the company's assets or liabilities or enter into transactions without effective compensation. Such decisions and transactions cannot, in any case, be made subject to the outcome of the bid. Decisions that have been sufficiently implemented prior to receipt of the FSMA's notification can be further executed by the board; however, the FSMA and the bidder should be immediately notified of any such decisions, which should also be made public.
- Issuance of convertible bonds or subscription rights (warrants): these instruments may be issued by the general meeting of shareholders and may, for example, be convertible or exercisable upon the launch of a takeover bid. It is also possible to create a pyramidal ownership structure or issue share certificates.
As a general rule, in keeping with the Takeover Directive, the target company's board of directors must act in the company's interest. It may, therefore, seek out an alternative bidder (or white knight). Belgian law specifically provides that the target company need not inform the FSMA of the fact that it is searching for an alternative bidder (while it should inform the bidder and the FSMA of any decision in relation to the issuance of shares or that is liable to frustrate the bid).
Belgium has opted out of the provisions of the Takeover Directive aimed at restricting the use of defensive measures by the board of directors. Nevertheless, companies with their registered office in Belgium whose shares are (at least partially) listed on a regulated market may voluntarily include such restrictions in their articles of association (i.e., opt in).
In this regard, a company may provide in its articles of association that:
- during the offer period, the board of directors (or the body to whom the relevant powers have been delegated) may not take any action (other than seeking alternative bids) liable to result in frustration of the bid without the prior consent of the general meeting of shareholders;
- any decisions taken prior to the offer period that are not yet fully implemented and that could frustrate the bid can only be further implemented with the prior consent of the general meeting of shareholders (except for those taken in the ordinary course of business);
- restrictions on share transfers expressed in the articles of association or a shareholders' agreement shall not apply to the bidder during the acceptance period or after the bid if the bidder holds at least 75 per cent of the target's share capital;
- restrictions on voting rights expressed in either the articles of association or a shareholders' agreement shall not apply at a general meeting held during the offer period for the purpose of adopting measures to frustrate the bid or after the offer if, as a result of the offer, the bidder holds at least 75 per cent of the target's capital; and
- provisions of the articles allowing a shareholder to appoint or remove a director shall not apply at the first general meeting called by the bidder after the offer, provided the bidder holds at least 75 per cent of the target's capital as a result of its bid.
If the rights set out in (c) to (e) cannot be exercised, reasonable compensation should be paid to their holders.
The company may also stipulate in its articles of association that such provisions shall only apply to the extent the bidder or the company controlling the bidder is subject to the same restrictions on the application of defensive measures (the reciprocity rule).
The use of staggered boards as a takeover defence is not relevant in Belgium, as a director of a public limited company can always be removed at will by the general meeting of shareholders.
v Contact with shareholders
The basic rule is that the company should treat all similarly situated shareholders equally.
The Royal Decree of 24 November 200728 regulates periodic (annual and semi-annual) and occasional information (i.e., inside information) to be disclosed by listed companies, in addition to the mandatory disclosures set out in the BCCA (e.g., annual accounts and annual reports). Periodic information should be disclosed quickly and on a non-discriminatory basis so that it can reach as many people as possible, and disclosure should take place, insofar as possible, simultaneously in Belgium and other member states of the EEA. The company should use media that are expected to ensure disclosure in all member states of the EEA. Any inside information should be disclosed as simultaneously as possible to all categories of investors in the member states where the company has requested or agreed to trade its financial instruments on a regulated market.
The 2020 Code stipulates that the board should ensure an effective dialogue with shareholders and potential shareholders through appropriate investor relation programmes, in order to achieve a better understanding of their objectives and concerns. Feedback of such dialogue should be given to the board, on at least an annual basis. Individual meetings with institutional investors are also encouraged to receive explanations on their voting behaviour. It is indeed common practice for companies to hold individual meetings with their controlling shareholders, institutional shareholders, or both. However, the information disclosed in these meetings should be information that is already public or that is made public at the same time, to avoid the unequal treatment of shareholders.
Each director has a duty to keep information about the company confidential unless required to disclose it pursuant to a statutory or ethical duty. This duty also extends to companies' shareholders. Some scholars argue, however, that directors representing a controlling shareholder can consult with that shareholder on decisions to be taken by the board of directors and the position the director will adopt in future deliberations, unless the board of directors specifically decides otherwise. This does not mean that the directors can inform the person they represent of information he or she can then use for his or her own purposes (e.g., to determine whether to sell or purchase shares).
In addition to this general duty of confidentiality, it is also forbidden for anyone in possession of inside information (e.g., directors) to, inter alia, disclose such information to anyone else except in the normal course of business or in the performance of his or her professional duties.
The general rule is that inside information should be immediately disclosed. However, a company can decide, at its own risk, to postpone the disclosure of inside information if the disclosure could harm the company's legitimate interests, provided that the delay in disclosure does not mislead the public and confidentiality can be guaranteed. If inside information is disclosed in the normal exercise of the discloser's profession, function or work, the information should simultaneously be made public unless the person to whom the inside information is disclosed is bound by a duty of confidentiality (e.g., the printer or the communications department). If the disclosure of inside information is postponed, the company should take the necessary measures to, inter alia, bar access to this information to all persons who do not need it to exercise their functions.
Based on the foregoing, in our opinion, directors cannot disclose inside information to a shareholder further to a confidentiality agreement. The only exception to this rule is if a third party or a shareholder requests information from the company to determine, for example, the appropriateness of making a public offer, in which case the board of directors can grant access to the information in question if it enters into a confidentiality agreement that includes a standstill clause (i.e., no transactions in the company's shares until the information has been made public) and provided disclosure is in the company's interest.
Belgian law has be subject to important changes over the past year. In addition, the Shareholders Rights Directive II has not yet been implemented in Belgian law. SRD II will have an additional material impact on the governance of listed companies.
1 Elke Janssens is a partner at NautaDutilh in Brussels.
3 Publieke Veilingen/Ventes Publiques, Trading Facility and Easynext, organised by Euronext Brussels, and MTS Belgium, MTS Denmark and MTS Finland, organised by MTS Associated Markets SA, are also MTFs but are rarely used.
4 Since most listed companies in Belgium take the form of an NV/SA, the governance structures of other corporate forms are not discussed in this chapter.
5 See: Article 7:101 Section 1 par. 3.BCCA.
6 Applicable as from the first day of the first financial year starting after 14 September 2011.
7 In a two-tier structure, the chair of the supervisory board and the CEO should set the agenda of their respective board meetings, in consultation with the company secretary.
8 There is an exception for small listed companies that meet the criteria set out in Article 7:100 Section 4 BCCA. In that case, no remuneration committee need be set up. Rather, the board of directors will perform the duties of the remuneration committee and should have at least one independent member. If the chairperson of the board is an executive director, he or she cannot chair board meetings when the board is acting as the remuneration committee. There is also an exception for public undertakings for collective investment with variable capital, within the meaning 3, 5° of the Act of 3 August 2012 on institutions for collective investments that meet the conditions of Directive 2009/65/EC and for companies whose business is the issuance of asset-backed securities, as defined in Article 2(5) of Commission Regulation (EC) No. 809/2004.
9 In accordance with the requirements set out in Clause 3.5 of the 2020 Code and Article 7:87 BCAA.
10 There is an exception for small listed companies that meet the criteria set out in Article 7:99Section 3 BCCA. In that case, no audit committee need be set up. Rather, the board of directors will perform the tasks of the audit committee and should have at least one independent member. If the chairperson of the board is an executive director, he or she cannot chair board meetings at which the board is acting as the audit committee. There is also an exception for public undertakings for collective investment with variable capital, within the meaning of 3, 5° of the Act of 3 August 2012 on institutions for collective investments that meet the conditions of Directive 2009/65/EC, and for companies whose business is the issuance of asset-backed securities, as defined in Article 2(5) of Commission Regulation (EC) No. 809/2004.
11 In accordance with the requirements set out in Clause 3.5 of the 2020 Code and Article 7:87 BCAA.
12 The Code 2020 provides that the remuneration policy should be submitted for approval to the shareholders' meeting.
13 This rule applies to any agreements entered into or renewed as from 3 May 2010.
14 For non-executive dependent directors, this rule applies to any agreements entered into or renewed after 3 December 2011.
15 Holding directly or indirectly a majority of the share capital or voting rights, or having the power to appoint a majority of the members of the governing or executive body or to appoint a person entrusted with governmental supervision including by means of a contract.
16 Act of 19 December 2012 on the remuneration of employees and office holders in institutions of public utility, autonomous governmental companies and legal entities over which the state exerts, directly or indirectly, a preponderant influence, published in the Belgian State Gazette on 28 January 2013, entered into force on 1 August 2013.
17 Clause 3.5 of the 2020 Code and article 7:87 BCAA.
18 Some of the provisions also apply to companies whose securities or shares are listed on certain MTFs.
19 The latter is applicable to companies whose shares or debt instruments are listed.
20 Act of 1 April 2007 on public takeover bids.
21 These requirements are applicable to companies whose shares are listed on a regulated market. The requirements under (a), (b) and (i) are also applicable to companies whose securities, other than shares, are listed on a regulated market when their shares are listed on an MTF. The requirement set out under (c) is also applicable to companies whose securities are listed on a regulated market.
22 The term CEO can refer here to the main representative of the executive directors, the chairperson of the management committee, the main representative of 'other leaders' or the main representative of the persons entrusted with daily management of the company.
23 Except as mentioned in Article 7:155 BCCA.
24 It is generally accepted that, in certain cases, some powers can be delegated.
25 Article 7:144 BCCA.
26 Article 7:145 BCCA.
27 Act of 28 March 2014 on class actions, Belgian State Gazette, 29 April 2014.
28 Royal Decree of 24 November 2007 on the obligations of issuers of financial instruments traded on a regulated market, Belgian State Gazette, 3 December 2007.